Now approved in the US: PAPZIMEOS^™

Learn more about PAPZIMEOS (zopapogene imadenovec-drba) for subcutaneous injection 5×10¹¹ PU/mL

• Read Precigen’s press release
• Read RRPF’s press release
• Read the FDA’s press release
• Visit the product website
• Read the full prescribing information